Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
127,940,509
-
Total 13F shares
-
77,562,435
-
Share change
-
+333,624
-
Total reported value
-
$311,007,504
-
Put/Call ratio
-
817%
-
Price per share
-
$4.01
-
Number of holders
-
159
-
Value change
-
-$4,129,971
-
Number of buys
-
78
-
Number of sells
-
83
Institutional Holders of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) as of Q1 2025
As of 31 Mar 2025,
Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,562,435 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, HHLR ADVISORS, LTD., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, NEW YORK STATE COMMON RETIREMENT FUND, Topline Capital Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.